Singapore to build vaccine manufacturing capacity amid pandemic: PM Lee
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SINGAPORE] Singapore is building up its vaccine manufacturing capacity in order to offer fill and finish contract manufacturing services to vaccine developers, Prime Minister Lee Hsien Loong said in published remarks delivered at a summit.
The effort is aimed at helping companies ramp up production faster and assure them high standards of safety and quality in the manufacturing process, Mr Lee said.
The country is investing heavily in research and development on diagnostics, vaccines and therapeutics, he said. Singapore researchers have developed a range of serological and nucleic acid-based diagnostic tests, which have been deployed to over 20 countries. Researchers are also developing therapeutic monoclonal antibodies as well as a vaccine and have started clinical trials of various therapeutics, he added.
BLOOMBERG
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
